about the paper, i mentioned my concerns this week
Post# of 148154
(Total Views: 548)
Posted On: 03/27/2020 6:42:11 PM
Re: BrooklynEIPA #23584
about the paper, i mentioned my concerns this week. I guess others are seeing some also.... link back
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Quote: A total of 26 patients received hydroxychloroquine and 16 were control patients. Six hydroxychloroquine-treated patients were lost in follow-up during the survey because of early cessation of treatment. Reasons are as follows: three patients were transferred to intensive care unit, including one transferred on day2 post-inclusion who was PCR-positive on day1, one transferred on day3 post-inclusion who was PCR-positive on days1-2 and one transferred on day4 post-inclusion who was PCR-positive on day1 and day3; one patient died on day3 post inclusion and was PCR-negative on day2; one patient decided to leave the hospital on day3 post-inclusion and was PCR-negative on days1-2; finally, one patient stopped the treatment on day3 post-inclusion because of nausea and was PCR-positive on days1-2-3.
Read More: https://investorshangout.com/post/view?id=571...z6Hvr6GPGX
Read More: https://investorshangout.com/post/view?id=571...z6HvqZd7TM
Quote:
I looked at the paper briefly. I believe is connected to this today, I believe some news saying 100% effective. I found something very concerning with that, if this is indeed the paper. I haven’t had a lot of time to look. Some patients were lost to follow up because they were transferred to ICU....that to me seems very bad Is that any better than without the drug? How long were they on the drug....etc, etc
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Quote: A total of 26 patients received hydroxychloroquine and 16 were control patients. Six hydroxychloroquine-treated patients were lost in follow-up during the survey because of early cessation of treatment. Reasons are as follows: three patients were transferred to intensive care unit, including one transferred on day2 post-inclusion who was PCR-positive on day1, one transferred on day3 post-inclusion who was PCR-positive on days1-2 and one transferred on day4 post-inclusion who was PCR-positive on day1 and day3; one patient died on day3 post inclusion and was PCR-negative on day2; one patient decided to leave the hospital on day3 post-inclusion and was PCR-negative on days1-2; finally, one patient stopped the treatment on day3 post-inclusion because of nausea and was PCR-positive on days1-2-3.
Read More: https://investorshangout.com/post/view?id=571...z6Hvr6GPGX
Read More: https://investorshangout.com/post/view?id=571...z6HvqZd7TM
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼